Skip to content

Scientific infrastructure for cannabinoid evidence

MaryGenAI

Project for scientific data sources, ontology design, and human-reviewed curation of cannabinoid therapy evidence.

Source evaluation Ontology design Human review

Evidence Record

Field-level provenance snapshot

v0.1
Publication Type
Systematic Review
Study Design
Human Clinical Trial
Compound
Cannabidiol (CBD)
Review Status
Human verified

Provenance

Each extracted claim is linked to a source record, extraction method, confidence score, evidence text, and reviewer state.

The Knowledge Graph

A structured ontology for cannabinoid evidence.

MaryGenAI models publications, clinical trial records, compounds, receptors, ligands, medical conditions, routes of administration, dosing objectives, adverse events, and human review state as connected evidence objects.

Publication

PMID / DOI / abstract

Compound

CBD / THC / CBG

Study Design

RCT / cohort / in vitro

Receptor

CB1 / CB2 / TRPV1

Dosing Objective

Safety / effective dose

Curation Pipeline

Designed for provenance before scale.

Every extracted field is treated as a claim with source, method, confidence, evidence text, and review status. Human review is tracked at field level, not only at record level.

01

Source Intake

Candidate APIs and datasets are tested in small reproducible batches.

02

Normalization

Records are mapped into publication, trial, interaction, and evidence claim objects.

03

Assisted Extraction

Models classify fields only when evidence and confidence can be stored.

04

Human Review

Reviewers verify field values, corrections, notes, timestamps, and ontology version.

Latest Research

Semantic Scholar API mockup.

This interface sketch shows how MaryGenAI could distinguish publication type from study design while preserving source identifiers and ontology-ready fields.

Mock API response